| 000 | 01698 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515234631.0 | ||
| 264 | 0 | _c20101122 | |
| 008 | 201011s 0 0 eng d | ||
| 022 | _a1938-0666 | ||
| 024 | 7 |
_a10.3816/CBC.2010.n.041 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade la Haba-Rodriguez, Juan | |
| 245 | 0 | 0 |
_aExemestane and chemotherapy as first-line treatment of metastatic breast cancer: results of a phase II study. _h[electronic resource] |
| 260 |
_bClinical breast cancer _cAug 2010 |
||
| 300 |
_a313-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAndrostadienes _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMancha, Rosario González | |
| 700 | 1 | _aManga, Gumersindo Pérez | |
| 700 | 1 | _aAguilar, Enrique Aranda | |
| 700 | 1 | _aBaena Cañada, José Manuel | |
| 700 | 1 | _aRovira, Pedro Sánchez | |
| 700 | 1 | _aConejo, Emilio Alba | |
| 773 | 0 |
_tClinical breast cancer _gvol. 10 _gno. 4 _gp. 313-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3816/CBC.2010.n.041 _zAvailable from publisher's website |
| 999 |
_c20043059 _d20043059 |
||